Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ROVI
Manufacturing
Rovi warns analyst profit consensus is 10% to 15% too high
Spanish CDMO Rovi is part of a parade of biopharma contractors struggling to keep their manufacturing businesses growing in a post-COVID world.
Fraiser Kansteiner
Feb 13, 2025 9:58am
Granules receives Form 483 over poor document controls and more
Sep 19, 2024 10:11am
Rovi receives offers for potential sale of €2B-plus CDMO group
Jun 27, 2024 2:21pm
Rovi wins FDA nod to make Moderna's COVID shot at Spanish plant
Feb 28, 2024 11:22am
